Pre-publication Release
Remestemcel-L Therapy for COVID-19-Associated Multisystem Inflammatory Syndrome in Children
Allison Ross Eckard, Kenneth M. Borow, Elizabeth H. Mack, Elizabeth Burke and Andrew M. Atz
Pediatrics February 2021, e2020046573; DOI: https://doi.org/10.1542/peds.2020-046573
Allison Ross Eckard
1Medical University of South Carolina, Department of Pediatrics, Charleston, SC, USA;
Kenneth M. Borow
2Borow Consulting Group, Bryn Mawr, PA, USA;
Elizabeth H. Mack
1Medical University of South Carolina, Department of Pediatrics, Charleston, SC, USA;
Elizabeth Burke
3Mesoblast, Inc., New York, NY, USA
Andrew M. Atz
1Medical University of South Carolina, Department of Pediatrics, Charleston, SC, USA;


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Log in
You will be redirected to aap.org to login or to create your account.
Remestemcel-L Therapy for COVID-19-Associated Multisystem Inflammatory Syndrome in Children
Allison Ross Eckard, Kenneth M. Borow, Elizabeth H. Mack, Elizabeth Burke, Andrew M. Atz
Pediatrics Feb 2021, e2020046573; DOI: 10.1542/peds.2020-046573
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.